- Home
- LOCO vs NPCE Comparison
LOCO vs NPCE Comparison
Compare LOCO & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- NPCE
- Stock Information
- Founded
- LOCO 1980
- NPCE 1997
- Country
- LOCO United States
- NPCE United States
- Employees
- LOCO N/A
- NPCE N/A
- Industry
- LOCO Restaurants
- NPCE Medical Specialities
- Sector
- LOCO Consumer Discretionary
- NPCE Health Care
- Exchange
- LOCO Nasdaq
- NPCE Nasdaq
- Market Cap
- LOCO 323.7M
- NPCE 292.9M
- IPO Year
- LOCO 2014
- NPCE 2021
- Fundamental
- Price
- LOCO $10.63
- NPCE $9.15
- Analyst Decision
- LOCO Buy
- NPCE Strong Buy
- Analyst Count
- LOCO 2
- NPCE 6
- Target Price
- LOCO $18.00
- NPCE $16.67
- AVG Volume (30 Days)
- LOCO 175.1K
- NPCE 205.3K
- Earning Date
- LOCO 10-30-2025
- NPCE 08-12-2025
- Dividend Yield
- LOCO N/A
- NPCE N/A
- EPS Growth
- LOCO N/A
- NPCE N/A
- EPS
- LOCO 0.85
- NPCE N/A
- Revenue
- LOCO $479,690,000.00
- NPCE $88,570,000.00
- Revenue This Year
- LOCO $6.29
- NPCE $22.13
- Revenue Next Year
- LOCO $1.56
- NPCE $6.07
- P/E Ratio
- LOCO $12.53
- NPCE N/A
- Revenue Growth
- LOCO 1.85
- NPCE 23.32
- 52 Week Low
- LOCO $8.29
- NPCE $5.45
- 52 Week High
- LOCO $14.10
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- LOCO 52.39
- NPCE 51.74
- Support Level
- LOCO $10.40
- NPCE $8.61
- Resistance Level
- LOCO $10.74
- NPCE $8.99
- Average True Range (ATR)
- LOCO 0.26
- NPCE 0.53
- MACD
- LOCO 0.04
- NPCE 0.11
- Stochastic Oscillator
- LOCO 75.57
- NPCE 75.00
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.